Patients taking liraglutide (Victoza, Novo Nordisk) were at increased risk for gallbladder and biliary tract-related events in the LEADER trial but the mechanisms are unclear, a post-hoc analysis has ...
My patient’s symptoms are consistent with biliary dysfunction (right-upper-quadrant pain after eating), and an N-para-isopropyl-acetanilide-iminodiacetic acid (PIPIDA) scan shows mild dysfunction. An ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback